These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 369299)

  • 1. Preliminary clinical test of zimelidine (H 102/09), a new 5-HT uptake inhibitor.
    Aberg A; Holmberg G
    Acta Psychiatr Scand; 1979 Jan; 59(1):45-58. PubMed ID: 369299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
    Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
    Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 5-hydroxytryptamine reuptake by amitryptyline an zimelidine and its relationship to their therapeutic action.
    Coppen A; Rama Rao VA; Swade C; Wood K
    Psychopharmacology (Berl); 1979 May; 63(2):125-9. PubMed ID: 112630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zimelidine: a therapeutic and pharmacokinetic study in depression.
    Coppen A; Ramo Rao VA; Swade C; Wood K
    Psychopharmacology (Berl); 1979 Jun; 63(3):199-202. PubMed ID: 113803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment.
    Ross SB; Aberg-Wistedt A
    Psychopharmacology (Berl); 1983; 79(4):298-303. PubMed ID: 6222388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxytryptamine mechanisms. Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine.
    Fuxe K; Ogren SO; Agnati LF
    Neurosci Lett; 1979 Aug; 13(3):307-12. PubMed ID: 530482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind controlled study of seratonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients.
    Johansson F; Von Knorring L
    Pain; 1979 Aug; 7(1):69-78. PubMed ID: 388295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of zimelidine, a selective 5-HT uptake inhibitor, on serum prolactin levels in man.
    Syvälahti E; Nagy A; van Praag HM
    Psychopharmacology (Berl); 1979 Sep; 64(3):251-3. PubMed ID: 116266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical effects of zimelidine in man.
    Bertilsson L; Tuck JR; Siwers B
    Eur J Clin Pharmacol; 1980 Nov; 18(6):483-7. PubMed ID: 6450684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between zimelidine and desipramine in endogenous depression. A cross-over study.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Aug; 66(2):129-38. PubMed ID: 6215831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-aggressive effect of zimelidine in isolated mice.
    Ogren SO; Holm AC; Renyi AL; Ross SB
    Acta Pharmacol Toxicol (Copenh); 1980 Jul; 47(1):71-4. PubMed ID: 6446833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients.
    Siwers B; Ringberger VA; Tuck JR; Sjöqvist F
    Clin Pharmacol Ther; 1977 Feb; 21(2):194-200. PubMed ID: 837638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of zimelidine and norzimelidine in endogenous depression.
    Hansen LB; Thomsen IS; Vestergård P; Larsen NE; Hvidberg EF
    Psychopharmacology (Berl); 1980; 69(2):157-60. PubMed ID: 6450427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Georgotas A; Krakowski M; Gershon S
    Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.
    Linnoila M; Karoum F; Calil HM; Kopin IJ; Potter WZ
    Arch Gen Psychiatry; 1982 Sep; 39(9):1025-8. PubMed ID: 6214234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An examination of possible interactions between zimelidine, a serotonin uptake inhibitor, and ethanol ingested conjointly in human subjects.
    Brown ZW; Amit Z; Sutherland A; Rockman G; Selvaggi N; Ogren SO
    Neurosci Lett; 1981 Dec; 27(3):351-5. PubMed ID: 6460207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of zimelidine and desipramine in endogenous depression.
    Lingjaerde O; Bratfos O; Bratlid T; Haug JO
    Acta Psychiatr Scand; 1983 Jul; 68(1):22-30. PubMed ID: 6225313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.